Lisa Ridnour

6PUBLICATIONS
38CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 02, 2024
Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast Cancer.

Lisa A Ridnour, William F Heinz, Robert Y S Cheng

|Aug 02, 2024
TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers.

Manjari Kundu, Yoshimi E Greer, Alexei Lobanov

|Jun 19, 2024
NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.

Leandro L Coutinho, Elise L Femino, Ana L Gonzalez

|May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome.

Robert Y S Cheng, Lisa A Ridnour, Adelaide L Wink

|Feb 25, 2023
Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells.

Robert Y S Cheng, Sandra Burkett, Stefan Ambs

|Oct 20, 2019
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.

Anthony L Schwartz, Pulak R Nath, Michael Allgauer

Pageof 1

Frequent Collaborators

4 joint publications

Stephen J Lockett

4 joint publications

Robert Y S Cheng

3 joint publications

David A Wink

3 joint publications

Stefan Ambs